Sun Pharma
-
India-based drug makers recall products in US market
Sun Pharma, Dr Reddy’s Laboratories, Aurobindo Pharma and Jubilant Pharma for some or other reasons Sun Pharma, Dr Reddy’s Laboratories,…
Read More » -
Sun Pharma announces publication of ILUMYA’s five-year efficacy results
The results were announced at British Journal of Dermatology Sun Pharmaceutical Industries, USA (Sun Pharma) announced the publication of five-year…
Read More » -
Sun Pharma launches website for LTC portfolio in US
The new website highlights the efficacy and safety profile for each product, while also educating healthcare providers and patients about…
Read More » -
Sun Pharma to launch Brivaracetam for epilepsy treatment in India
Company to introduce Brevipil tablet 25 mg/50 mg/75 mg/100 mg, oral solution (10 mg/ml) and injectable (10 mg/ml) Sun Pharmaceutical…
Read More » -
Sun Pharma posts Q3FY21 results
In Q3, the net profit is at Rs 1,852 crores up 103 per cent YoY Sun Pharmaceutical Industries has reported…
Read More » -
Sun Pharma announces initiation of Phase 2 clinical trial of SCD-044
The study in patients with moderate to severe plaque psoriasis will enrol approximately 240 subjects and topline results are expected…
Read More » -
Sun Pharma posts Q2FY21 results
Gross sales was at Rs 8,459 crores up 6 percent YoY and Q2 adjusted net profit is at Rs 1,590…
Read More » -
Dr Harsh Vardhan launches clinical trials website ‘CUReD’
The website will provide information about COVID-19 drugs, diagnostics and devices including current stage of trials Dr Harsh Vardhan, Minister…
Read More » -
Sun Pharma recalls diabetes drug in the US market
Sun Pharma is recalling 747 bottles of generic diabetes drugs in the US due to the possibility of the affected…
Read More »